#AACR25
The AACR Annual Meeting is the touchstone event for the cancer research community. #AACR25 convened 22,000 attendees from 85 countries to explore and expand the continuum of cancer science and medicine. Learn more in the AACR Annual Impact Report:
buff.ly/PSiw06M
March 4, 2026 at 6:16 PM
“I think this is tremendous. Now immunotherapy will be here and present for our head and neck [cancer] patients undergoing cancer resection,” said @danafarbernews.bsky.social’s Glenn Hanna, MD, in an Oncology Times article describing clinical trials presented at #ASCO25 and #AACR25. bit.ly/4qF4ID9
bit.ly
Glenn Hanna, MD, of Dana-Farber Cancer Institute
bit.ly
January 7, 2026 at 4:30 PM
Honored to be included in this #SABCS25 session highlighting #AACR25 work!

Thank you to Drs. Charles Perou and Carlos Arteaga for moderating, and to AACR for organizing. Grateful as well to
Dr. Jenn Guerriero and many collaborators whose support and insight shaped this research!
Best of AACR 2025: #AACRFellows Charles M. Perou and Carlos L. Arteaga moderated an #SABCS25 educational session that featured high-impact #AACR25 presentations from Paul S. Mischel, Piro Lito, Yun Yan, and Kenichi Shimada.
@kenichi-shimada.bsky.social
December 12, 2025 at 1:08 AM
Best of AACR 2025: #AACRFellows Charles M. Perou and Carlos L. Arteaga moderated an #SABCS25 educational session that featured high-impact #AACR25 presentations from Paul S. Mischel, Piro Lito, Yun Yan, and Kenichi Shimada.
@kenichi-shimada.bsky.social
December 9, 2025 at 9:08 PM
🎥 Mario Perro, PhD, highlights GRC 65327, a selective Cbl-b inhibitor:

🚀 Boosts T/NK cell activity, restores T cell function & enhances anti–PD-1 responses in solid tumor models. Favorable safety profile supports further study

🔗 buff.ly/hBycSv4

@theaacr.bsky.social #AACR25 #Oncology #ImmunoOnc
First-in-class Cbl-b inhibitor GRC 65327 in solid tumors - VJOncology
Mario Perro, PhD, Ichnos Glenmark Innovation, New York, NY, discusses the preclinical profile of GRC 65327, a highly selective and...
buff.ly
September 10, 2025 at 11:46 AM
Two powerful conversations on Believe in Progress from #AACR25, Rodney and Erika McLeod share how cancer shaped their mission in youth education, and AACR Foundation President and Chairman, Stephen Ryan, reflects on advocacy. Listen to the latest episode: www.youtube.com/playlist?lis...
August 20, 2025 at 6:11 PM
At the AACR Annual Meeting 2025, AACR President Dr. Lillian L. Siu became the organization's new president. Learn more about her contributions to cancer research: leadingdiscoveries.aacr.org/dr-lillian-l-siu-at-the-leading-edge-of-drug-development/ #AACR25
August 11, 2025 at 9:07 PM
“Let us remind the world what we have long known—that cancer research saves lives.”
#AACR25 attendees stood together and raised their voices to support cancer research. Join them and ask Congress to preserve our investment in NIH:
buff.ly/1hGcoZ2
#FundNIH
August 11, 2025 at 8:15 PM
Missed BLOODPAC at AACR25? We’ve got a second chance for you. Join us Aug 20 @ 11AM ET for “Performance with Purpose", a seminar on metrics that matter for public health.

Don’t miss it. Register here: www.eventbrite.com/e/performanc...

#EarlyDetection #CancerScreening #LiquidBiopsy #PublicHealth
July 30, 2025 at 8:38 PM
“Every voice is important.”
At #AACR25, AACR Past President Patricia LoRusso emphasized the importance of a collective response to threats to the research enterprise. Please join her in calling on Congress to reject the President’s FY26 budget and preserve NIH funding.
buff.ly/EkH5EcK
July 28, 2025 at 3:58 PM
Look back at #AACR25—
Tingting Zhai, PhD, receives the 2025 Cancer Prevention Research Award for Outstanding Journal Article. Learn more: buff.ly/TIeSu2X #CancerPrevention
July 25, 2025 at 9:43 PM
A Big Ten CRC study, BTCRC-BRE19-409, was presented at #AACR25 by Darian Louthan at UW Carbone Cancer Center.

Congratulations to all co-authors and study teams whose hard work led to this publication!

Read more: bigtencrc.org/btcrc-bre19-...
July 15, 2025 at 6:52 PM
When clinical trials are disrupted, the results extend beyond research community.

“This is a human cost of instability. This is what it means when a system BUILT TO SERVE patients begins to falter.”

"When science is silenced, patients pay the price."

-Patricia LoRusso
🧪 x.com/aacr/status/...
AACR on X: "At #AACR25, AACR Past President Patricia LoRusso highlighted how the President’s proposed cuts to the NIH budget will disrupt clinical trials and harm patients. Join her in calling on Congress to preserve the nation’s investment in biomedical research: https://t.co/sxUEWUovJS https://t.co/EKf9qrCcIc" / X
At #AACR25, AACR Past President Patricia LoRusso highlighted how the President’s proposed cuts to the NIH budget will disrupt clinical trials and harm patients. Join her in calling on Congress to preserve the nation’s investment in biomedical research: https://t.co/sxUEWUovJS https://t.co/EKf9qrCcIc
x.com
July 12, 2025 at 11:47 PM
#Diagnostics is no longer a test—it’s a system.

At #ASCO25 & #AACR25, multimodal tools like cfDNA fragmentomics & AI-led decision platforms took centre stage.

We’re building the infra to make these plug-and-play.

Read the full article here: 👇
hurdle.bio/blog/the-fut...
The Future of Oncology: Multimodal Biomarkers, Liquid Biopsies, AI-Driven Precision and more at AACR | ASCO 2025 - Hurdle
This year’s ASCO and AACR conferences showcased a powerful shift toward diagnostics and treatment approaches that combine biological depth with […]
hurdle.bio
July 8, 2025 at 11:30 AM
At #AACR25, AACR Past President Patricia LoRusso highlighted how the President’s proposal to cut the NIH budget by nearly 40% will disrupt clinical trials and harm patients. Join her in calling on Congress to preserve the nation’s investment in biomedical research: buff.ly/5HWewe0
July 7, 2025 at 6:31 PM
Researchers at #AACR25 shared how AACR Project GENIE is helping uncover insights about rare cancer, early-onset cancer, colorectal cancer, and tumor-agnostic therapy that could impact patient care. Learn more on the #AACRBlog: buff.ly/36pDIFP #AACRGENIE
July 3, 2025 at 3:06 PM
It was great to catch up with the #Lexogen team during the last #AACR25 and reflect on our collaboration progress!

Working on a commercial Live-seq workflow:
🔬 #FluidFM® OMNIUM subcellular biopsies
🧬 LUTHOR™ HD RNA-Seq prep
Capturing transcriptomes from <0.15 pg RNA while cells stay alive!
June 30, 2025 at 8:12 AM
Researchers at #AACR25 shared how AACR Project GENIE is helping uncover insights about rare cancer, early-onset cancer, colorectal cancer, and tumor-agnostic therapy that could impact patient care. Learn more on the #AACRBlog: www.aacr.org/blog/2025/06... #AACRGENIE
June 27, 2025 at 7:40 PM
Dostarlimab may eliminate the need for surgery in certain patients with dMMR #solidtumors. Presented at @theaacr.bsky.social conference #AACR25, from @cancertherapyadv.bsky.social.

bit.ly/3HGTCfx
bit.ly
June 25, 2025 at 7:56 PM
At #AACR25, AACR Past President Patricia LoRusso highlighted remarkable recent progress against cancer and discussed how that progress is under threat. Join her in asking Congress to reject the President’s FY26 budget and preserve the nation’s investment in NIH:
www.votervoice.net/AACR/Campaig...
June 23, 2025 at 8:23 PM
Honored to see our Director, Dr. Rakesh Jain, recognized for his pioneering work in intravital microscopy and the tumor microenvironment. A true visionary in cancer research!
#AACR25 #TME #IntravitalMicroscopy
June 17, 2025 at 8:10 PM